Renovaro Inc Sustainability Reports
The company operates as a biotechnology enterprise developing advanced allogeneic cell and gene therapies for cancer treatment and infectious diseases, while expanding its platform into AI-powered computational biology and biodefense diagnostics.
Sector: Manufacturing
Country: United States
Exchange: Nasdaq
1 reports from 2023 to 2023
Company Profile
The company operates as a biotechnology enterprise developing advanced allogeneic cell and gene therapies for cancer treatment and infectious diseases, while expanding its platform into AI-powered computational biology and biodefense diagnostics.
Reports
1 total
Limited sustainability disclosure available
This company only publishes Annual Reports without dedicated sustainability sections.
Years